These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 8889607)

  • 1. The contribution of "cure by dapsone monotherapy' to the reduction of prevalence of leprosy in the State of Orissa, India, 1983-1993.
    Patnaik PK; McDougall AC
    Indian J Lepr; 1996; 68(3):223-6. PubMed ID: 8889607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation of tests for monitoring drug compliance of leprosy out-patients under multi-drug therapy.
    Balakrishnan S; Kumar A; Rao BR; Patro TP
    Indian J Lepr; 1986; 58(4):555-9. PubMed ID: 3572097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Twenty five years follow up of MB leprosy patients retreated with a modified MDT regimen after a full course of dapsone mono-therapy.
    Jing Z; Zhang R; Zhou D; Chen J
    Lepr Rev; 2009 Jun; 80(2):170-6. PubMed ID: 19743621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidrug therapy in leprosy can prevent relapse--a retrospective study.
    Biswas S; Mondal KK
    Indian J Lepr; 2002; 74(4):313-8. PubMed ID: 12624979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiological shift in leprosy in a rural district of central India following introduction of multi-drug therapy (April 1986 to March 1992 and April 1992 to March 2002).
    Pandey A; Uddin MJ; Patel R
    Lepr Rev; 2005 Jun; 76(2):112-8. PubMed ID: 16038244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in new case-detection leprosy in Bihar, India.
    Vijayakumaran P; Prasad B; Krishnamurthy P
    Indian J Lepr; 2006; 78(2):145-51. PubMed ID: 16927849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The frequency of the appearance of perforating foot ulcers in patients with Hansen's disease as a function of treatment with disulone alone or with polychemotherapy].
    Mane I; Grauwin MY; Cartel JL
    Acta Leprol; 1995; 9(3):127-31. PubMed ID: 7631583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in leprosy over fifty years in Gudiyatham Taluk, Vellore, Tamil Nadu.
    Norman G; Raja Samuel Bhushanam JD; Samuel P
    Indian J Lepr; 2006; 78(2):167-85. PubMed ID: 16927851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The national leprosy eradication programme in India.
    Mittal BN
    World Health Stat Q; 1991; 44(1):23-9. PubMed ID: 2068822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection of MDT strategies through epidemiometric modeling.
    Lechat MF; Declercq EE; Misson CB; Vellut CM
    Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):296-301. PubMed ID: 2115904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integration of leprosy into GHS in India: a follow up study (2006-2007).
    Pandey A; Rathod H
    Lepr Rev; 2010 Dec; 81(4):306-17. PubMed ID: 21313976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on risk of leprosy relapses in China: relapses after treatment with dapsone monotherapy.
    Chen XS; Li WZ; Jiang C; Ye GY
    Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4):371-8. PubMed ID: 10700910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone.
    Sapkota BR; Shrestha K; Pandey B; Walker SL
    Lepr Rev; 2008 Dec; 79(4):425-8. PubMed ID: 19274989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relapses in leprosy patients treated with rifampicin plus dapsone after varying periods of dapsone monotherapy.
    Li HY; Ran SP; Weng XM; Li TG; Deng XH; Li FT
    Indian J Lepr; 2001; 73(1):1-10. PubMed ID: 11326592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse effects from multi-drug therapy in leprosy: a Brazilian study.
    Deps PD; Nasser S; Guerra P; Simon M; Birshner Rde C; Rodrigues LC
    Lepr Rev; 2007 Sep; 78(3):216-22. PubMed ID: 18035772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relapse rates in patients treated with dapsone monotherapy and combinations of dapsone and thiambutosine, thiacetazone, isoniazid and streptomycin in the pre-MDT era.
    Smith TC; Richardus JH
    Int J Lepr Other Mycobact Dis; 1994 Sep; 62(3):353-8. PubMed ID: 7525795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relapse as histoid leprosy after receiving multidrug therapy (MDT); a report of three cases.
    Shaw IN; Ebenezer G; Rao GS; Natrajan MM; Balasundaram B
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):272-6. PubMed ID: 11221089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global review of multidrug therapy (MDT) in leprosy.
    Noordeen SK; Lopez Bravo L; Daumerie D
    World Health Stat Q; 1991; 44(1):2-15. PubMed ID: 2068821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of multidrug therapy on leprosy in Baroda district (Gujarat).
    Chopra NK; Agarwal JS; Pandya PG
    Indian J Lepr; 1989 Apr; 61(2):179-89. PubMed ID: 2746026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fixed duration MDT in paucibacillary leprosy (classical and modified).
    Nadkarni NJ; Grugni A; Kini MS
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):25-8. PubMed ID: 8326177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.